MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Clinical features"

  • 2018 International Congress

    Cognitive function impacts gait, functional mobility and falls in Fragile X-Associated Tremor/Ataxia Syndrome

    J. O'Keefe, E. Robertson, B. Ouyang, D. Carns, Y. Liu, M. Swanson, B. Bernard, E. Berry-Kravis, D. Hall (Chicago, IL, USA)

    Objective: To investigate the associations between executive function and information processing speed and gait, turning and falls in fragile X premutation carriers (PMC) with and…
  • 2018 International Congress

    Which is the best condition to evaluate the decline in gait automaticity in people with Parkinson’s disease? A ParkiMob study

    M. d'Alencar, Y. Uscapi, J. Miranda, M. Piemonte (São Paulo, Brazil)

    Objective: To identify which is the most efficient condition in terms of distance and kind of concurrent task to identify the decline in gait automaticity…
  • 2018 International Congress

    The PDSAFE falls prevention programe for people with Parkinson’s: A multicentre randomised controlled trial

    A. Ashburn, R. Pickering, L. Rochester, H. Roberts, C. Ballinger, S. Hulbert, I. Marian, C. Fitton, E. McIntosh, V. Goodwin, A. Nieuwboer, S. Lamb, K. Chivers Seymour (Southampton, United Kingdom)

    Objective: The aim was to examine the effectiveness of an exercise and strategy based intervention (PDSAFE) for fall reduction. Background: Evidence suggests exercise-based interventions might…
  • 2018 International Congress

    Atypical presentation in 4 patients of Subacute Sclerosing Pan Encephalitis (SSPE), –widening phenotypic horizon

    P. Basu, A. Ghosal, S. Shubham, J. Ganguly, Y. Kumar, K. Kumar (Kolkata, India)

    Objective: To highlight atypical presentation of SSPE and to create high index of awareness about phenotypic spectrum of the disease especially in developing countries. Background:…
  • 2018 International Congress

    Accelerometer-based measures and analyses of nonmotor symptoms of patients with Parkinson’s Disease

    C. Virbel-Fleischman, Y. Retory, S. Hardy, J.C. Corvol, D. Grabli (Paris, France)

    Objective: Through the monitoring of patients with PD during ON and OFF states, we aim at studying the detection of nonmotor symptoms (NMS) changes during…
  • 2018 International Congress

    A study of correlation between screening tools for cognitive decline and gait status using three-dimensional gait analysis

    PJ. Park (Busan, Republic of Korea)

    Objective: The objective of this study is to evaluate the correlation between screening tool for dementia and gait status. Background: Gait impairment in patient with…
  • 2018 International Congress

    Prevalence of focal task specific lower extremity dystonia symptoms in runners

    R. Thompson, A. Hellman, D. Torres-Russotto (Lebanon, NH, USA)

    Objective: The objective of this study was to survey a group of self-identified runners to determine the prevalence of symptoms suspected to be lower extremity…
  • 2018 International Congress

    Cognitive function is associated with Balance in Parkinson Disease: Cross-sectional study in Cali-Colombia

    B. Munoz, J. Orozco, J. Valderrama, A. Navarro, Y. Castaño, J. Arango (Cali, Colombia)

    Objective: To describe the association between global cognition (MoCA) and balance (GDI) in patients with Parkinson disease. Background: More than 62% of patients with Parkinson…
  • 2018 International Congress

    Asynchronous Consultation in Movement Disorders: The East Africa Hub

    M. Dekker, S. Urasa, S. Guttman, W. Howlett, M. Guttman (Moshi, United Republic of Tanzania)

    Objective: Improving education and care in movement disorders through telemedicine. Background: In 2012, the Movement Disorders Society launched a telemedicine project to enable professionals from…
  • 2018 International Congress

    Antihypertensive medications have protective associations with PD outcomes in PD-hypertension

    V. Kotagal (Ann Arbor, MI, USA)

    Objective: We explored the associations between markers of clinical decline and antihypertensive use in subjects with both Parkinson disease (PD) and hypertension (HTN) Background: Comorbid…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 53
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley